رجوع
نطاق اليوم
KWD 31.21
KWD 32.94
نطاق 52 أسبوعًا
KWD 9.22
KWD 36.00
حجم التداول
503,564
متوسط 50 يوم / 200 يوم
KWD 32.62
/
KWD 22.22
الإغلاق السابق
KWD 31.75
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -107.8 | 0.3 |
| P/B | 13.1 | 2.9 |
| ROE % | -13.5 | 3.7 |
| Net Margin % | -7.0 | 3.8 |
| Rev Growth 5Y % | 15.3 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 38.380
+17.7%
Low: KWD 34.000
High: KWD 41.000
مكرر الربحية المستقبلي
61.9
ربحية السهم المستقبلية
KWD 0.513
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
270 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.700
KWD 1.680 – KWD 1.722
|
530 M | 1 |
| FY2029 |
KWD 1.307
KWD 1.291 – KWD 1.323
|
430 M | 1 |
| FY2028 |
KWD 0.987
KWD 0.978 – KWD 0.996
|
370 M | 2 |
النقاط الرئيسية
Revenue grew 15.32% annually over 5 years — strong growth
Debt/Equity of 0.15 — conservative balance sheet
Negative free cash flow of -2.93M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.89%
Capital efficient — spends only 1.66% of revenue on capex
النمو
Revenue Growth (5Y)
15.32%
Revenue (1Y)20.21%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-13.49%
ROIC-3.98%
Net Margin-6.97%
Op. Margin-3.49%
الأمان
Debt / Equity
0.15
Current Ratio5.11
Interest Coverage-1.02
التقييم
P/E Ratio
-107.77
P/B Ratio13.13
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.21% | Revenue Growth (3Y) | 19.01% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15.32% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 225.21M | Net Income (TTM) | -15.70M |
| ROE | -13.49% | ROA | -7.08% |
| Gross Margin | 74.31% | Operating Margin | -3.49% |
| Net Margin | -6.97% | Free Cash Flow (TTM) | -2.93M |
| ROIC | -3.98% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.15 | Current Ratio | 5.11 |
| Interest Coverage | -1.02 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -107.77 | P/B Ratio | 13.13 |
| P/S Ratio | 7.51 | PEG Ratio | -2.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.69B | Enterprise Value | 1.68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 225.21M | 187.34M | 159.01M | 138.58M | 127.36M |
| Net Income | -15.70M | -9.96M | -21.72M | -28.95M | -26.99M |
| EPS (Diluted) | -0.34 | -0.23 | -0.51 | -0.69 | -0.65 |
| Gross Profit | 167.35M | 141.98M | 121.87M | 108.81M | 104.43M |
| Operating Income | -7.85M | -3.29M | -21.46M | -29.71M | -25.42M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 221.69M | 203.73M | 196.83M | 195.39M | 208.02M |
| Total Liabilities | 92.84M | 99.82M | 101.16M | 94.39M | 95.47M |
| Shareholders' Equity | 128.85M | 103.91M | 95.67M | 101.00M | 112.55M |
| Total Debt | 19.24M | 68.69M | 69.29M | 67.43M | 67.45M |
| Cash & Equivalents | 35.55M | 27.55M | 31.02M | 15.28M | 32.76M |
| Current Assets | 120.42M | 99.22M | 88.00M | 98.08M | 127.05M |
| Current Liabilities | 23.56M | 30.61M | 30.43M | 23.75M | 24.29M |